Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study

BACKGROUND: The dose and time point for switching from clopidogrel to ticagrelor remain controversial, especially for Chinese acute coronary syndrome (ACS) patients with complicated coronary artery disease (CAD). Hence, the purpose of this study was to further explore the optimal dose and time point...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Ying, Wang, Ping, Wang, Xiao-Zeng, Zhao, Xin, Zhao, Wei, Zhou, Tie-Nan, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819042/
https://www.ncbi.nlm.nih.gov/pubmed/31567375
http://dx.doi.org/10.1097/CM9.0000000000000444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819042/
https://www.ncbi.nlm.nih.gov/pubmed/31567375
http://dx.doi.org/10.1097/CM9.0000000000000444

Ejemplares similares